MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$7,943,587
EPS
-$0.13
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development expenses
5,639,660
3,525,097
345,096.5*
6,357,290
General and administrative expenses
2,677,591
3,424,832
1,176,150.5*
3,003,636
Total operating expenses
8,317,251
6,949,929
1,521,247
9,360,926
Loss from operations
-8,317,251
-6,949,929
-1,521,247*
-9,360,926
Interest income
236,320
111,757
78,676*
78,426
Grant income
207,173
213,565
90,337.5*
-
Change in fair value of warrant liability
69,829
-254,955
-331,289.5*
-379,311
Other income (expense) net
373,664
580,277
500,303*
457,737
Net loss
-7,943,587
-6,369,652
-1,020,944
-8,903,189
Basic EPS
-0.13
-0.14
-0.031
-0.27
Diluted EPS
-0.13
-0.14
-0.031
-0.27
Basic Average Shares
60,794,335
45,212,103
32,841,484
33,202,001
Diluted Average Shares
60,794,335
45,212,103
32,841,484
33,202,001
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$236,320
(196.52%↑ Y/Y)
Grant income
$207,173
Net loss
-$7,943,587
(-48.56%↓ Y/Y)
Other income
(expense) net
$373,664
Change in fair value of
warrant liability
$69,829
(-73.20%↓ Y/Y)
Loss from operations
-$8,317,251
(-61.00%↓ Y/Y)
Total operating
expenses
$8,317,251
(61.00%↑ Y/Y)
Research and development
expenses
$5,639,660
(81.29%↑ Y/Y)
General and
administrative expenses
$2,677,591
(30.28%↑ Y/Y)
Buy us a coffee
MAIA Biotechnology, Inc. (MAIA)
MAIA Biotechnology, Inc. (MAIA)